{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:06Z","timestamp":1793059926165,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010069"],"award-info":[{"award-number":["2021A1515010069"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202102020075"],"award-info":[{"award-number":["202102020075"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112033","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T20:51:23Z","timestamp":1712868683000},"page":"112033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3\/IL-23 axis"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5969-4075","authenticated-orcid":false,"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-9837","authenticated-orcid":false,"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.intimp.2024.112033_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"Psoriasis. Lancet."},{"issue":"21","key":"10.1016\/j.intimp.2024.112033_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111574","article-title":"Current concepts of psoriasis immunopathogenesis","volume":"22","author":"Vi\u010di\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112033_b0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112033_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126561","article-title":"aberrations in lipid expression and metabolism in psoriasis","volume":"22","author":"Nowowiejska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2024.112033_b0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112033_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040493","article-title":"Effects of hypolipidemic drugs on psoriasis","volume":"13","author":"Matwiejuk","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2019.90343","article-title":"The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials","volume":"16","author":"Socha","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112033_b0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: a trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2024.112033_b0050","article-title":"Dihydroartemisinin alleviates imiquimod-induced psoriasis-like skin lesion in mice involving modulation of IL-23\/Th17 Axis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12967-023-04427-6","article-title":"MicroRNA-125a-5p regulates the effect of tregs on Th1 and Th17 through targeting ETS-1\/STAT3 in psoriasis","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.112033_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114473","article-title":"Benzoylaconitine alleviates progression of psoriasis via suppressing STAT3 phosphorylation in keratinocytes","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112033_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111344","article-title":"WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and keratin 17","volume":"127","author":"Ti","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"23","key":"10.1016\/j.intimp.2024.112033_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312793","article-title":"The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications","volume":"22","author":"Singh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112033_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114623","article-title":"Cell cycle dependence on the mevalonate pathway: role of cholesterol and non-sterol isoprenoids","volume":"196","author":"Lasunci\u00f3n","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112033_b0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.trecan.2020.11.008","article-title":"Targeting the mevalonate pathway in cancer","volume":"7","author":"Juarez","year":"2021","journal-title":"Trends Cancer."},{"issue":"2","key":"10.1016\/j.intimp.2024.112033_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FJC.0000000000000952","article-title":"Key enzymes for the mevalonate pathway in the cardiovascular system","volume":"77","author":"Zhang","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112033_b0090","doi-asserted-by":"crossref","first-page":"1124786","DOI":"10.3389\/fimmu.2023.1124786","article-title":"Crosstalk between cholesterol metabolism and psoriatic inflammation","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112033_b0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00403-009-0958-2","article-title":"Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids","volume":"301","author":"Buraczewska","year":"2009","journal-title":"Arch. Dermatol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112033_b0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12340962","article-title":"Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis","volume":"109","author":"Harris","year":"1997","journal-title":"J, Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdermsci.2022.05.006","article-title":"Tiamulin inhibits TNF-\u03b1 and alleviates psoriasis-like dermatitis","volume":"107","author":"Xiang","year":"2022","journal-title":"J. Dermatol. Sci."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.112033_b0110","article-title":"Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network","volume":"318","author":"Xie","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6257","key":"10.1016\/j.intimp.2024.112033_b0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2024.112033_b0125","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/jdv.18296","article-title":"Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence","volume":"36","author":"Liu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol. Clin."},{"issue":"4","key":"10.1016\/j.intimp.2024.112033_b0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112033_b0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-021-00590-y","article-title":"Psoriasis in patients with metabolic syndrome or type 2 diabetes mellitus: treatment challenges","volume":"22","author":"Pannu","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2024.112033_b0145","doi-asserted-by":"crossref","unstructured":"Fujimoto N, Akiyama M, Satoh Y, Tajima S. Interaction of Gal-7 with HMGCS1 InVitro May Facilitate Cholesterol Deposition in Cultured Keratinocytes. J Invest Dermatol. 2022;142(3 Pt A):539-48.","DOI":"10.1016\/j.jid.2021.04.038"},{"issue":"4","key":"10.1016\/j.intimp.2024.112033_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jmb.2010.03.034","article-title":"Crystal structures of human HMG-CoA synthase isoforms provide insights into inherited ketogenesis disorders and inhibitor design","volume":"398","author":"Shafqat","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2133.2010.09694.x","article-title":"Effects of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor and low-density lipoprotein on proliferation and migration of keratinocytes","volume":"163","author":"Abd El-Latif","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112033_b0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-0625.2010.01223.x","article-title":"Lipid peroxidation-induced VEGF expression in the skin of KKAy obese mice","volume":"20","author":"Nakai","year":"2011","journal-title":"Exp. Dermatol."},{"issue":"17","key":"10.1016\/j.intimp.2024.112033_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10275","key":"10.1016\/j.intimp.2024.112033_b0170","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112033_b0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.112033_b0185","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.1995","article-title":"Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis","volume":"15","author":"Caruso","year":"2009","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.112033_b0190","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1038\/jid.2014.308","article-title":"IL-19 is a component of the pathogenetic IL-23\/IL-17 cascade in psoriasis","volume":"134","author":"Witte","year":"2014","journal-title":"J, Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112033_b0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.intimp.2024.112033_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155535","article-title":"STAT3\/SH3PXD2A-AS1\/miR-125b\/STAT3 positive feedback loop affects psoriasis pathogenesis via regulating human keratinocyte proliferation","volume":"144","author":"Yang","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112033_b0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","article-title":"Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines?","volume":"126","author":"Baker","year":"1992","journal-title":"Br. J. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:04:34Z","timestamp":1715630674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924005514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"alternative-id":["S1567576924005514"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112033","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3\/IL-23 axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112033"}}